DERIVATIVES OF 3,6-DIAMINO-PYRIDAZIN-3YL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PROAPOPTOTIC AGENTS
WO2021018858A1
6,7-dihydro-5h-pyrido[2,3-c]pyridazine derivatives and related compounds as bcl-xl protein inhibitors and pro-apoptotic agents for treating cancer
WO2020254299A1
Combination of a mcl-1 inhibitor and a standard of care treatment for breast cancer, uses and pharmaceutical compositions thereof
WO2020229429A1
Bcl-2 inhibitors for use in the treatment of a bcl-2 mediated cancer carrying the gly101val mutation
WO2020165189A1
Method for the biosynthesis of diosmin and/or hesperidin in a microorganism
TW202039511A
New crystalline forms of a mcl-1 inhibitor, a process for their preparation and pharmaceutical compositions containing them
TW202038960A
Combination of a mcl-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereof
TW202031295A
Cyclodextrin-based formulation of a bcl-2 inhibitor
WO2020089281A1
Novel salt of a bcl-2 inhibitor, related crystalline form, method for preparing the same and pharmaceutical compositions containing the same
UY38423A
NEW AMINO-PYRIMIDONIL-PIPERIDINYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2020078875A1
New process for the synthesis of piperazinyl-ethoxy-bromophenyl derivates and their application in the production of compounds containing them
AR115701A1
AMINO-PYRIMIDONIL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY38291A
NEW AMINO-PYRIMIDONYL DERIVATIVES A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
AU2019284248A1
Polygenic risk scores for predicting disease complications and/or response to therapy
FR3092768A1
Containment device for rotary evaporator
WO2019134970A1
Novel salts of a bcl-2 inhibitor,related crystalline forms,method for preparing the same and pharmaceutical compositions containing the same
WO2019105963A1
New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7
US2018369252A1
Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it
FR3083980A1
PHARMACEUTICAL COMPOSITION IN THE FORM OF A CHEWABLE TABLET OF DIOSMINE OR A FLAVONOIC FRACTION
WO2019008126A1
New crystalline form of a bcl-2 inhibitor, a process for its preparation and pharmaceutical compositions containing it
